Anavex Life Sciences Corp.
AVXL · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$46 | -$43 | -$48 | -$48 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $12 | $9 | $16 | $18 |
| Change in WC | $0 | $3 | $3 | $5 |
| Other Non-Cash | -$4 | $0 | $1 | $0 |
| Operating Cash Flow | -$39 | -$31 | -$28 | -$24 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1 | $11 | $28 | $21 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9 | $1 | $2 | $0 |
| Financing Cash Flow | $9 | $12 | $30 | $21 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$30 | -$19 | $2 | -$3 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $132 | $151 | $149 | $152 |
| End Cash | $103 | $132 | $151 | $149 |
| Free Cash Flow | -$39 | -$31 | -$28 | -$24 |